Xtant Medical Stock Price, News & Analysis (NYSEAMERICAN:XTNT)

$5.88 -0.17 (-2.81 %)
(As of 02/23/2018 11:26 AM ET)
Previous Close$6.05
Today's Range$5.84 - $6.04
52-Week Range$3.96 - $14.52
Volume4,927 shs
Average Volume50,684 shs
Market Capitalization$149.32 million
P/E Ratio-0.31
Dividend YieldN/A
Beta0.41

About Xtant Medical (NYSEAMERICAN:XTNT)

Xtant Medical Holdings, Inc., formerly Bacterin International Holdings, Inc., develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The Company operates through the development, manufacture and marketing of regenerative medical products and devices segment. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, BacFast HD, OsteoSTX, hMatrix and 3Demin products, as well as other allografts. Its products serve the needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, foot and ankle surgeries. It also processes and distributes sports allografts, milled spinal allografts and allografts for multi-disciplinary applications.

Receive XTNT News and Ratings via Email

Sign-up to receive the latest news and ratings for XTNT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Advanced Medical Equipment & Technology
Sub-IndustryN/A
SectorHealthcare
SymbolNYSEAMERICAN:XTNT
CUSIPN/A
Phone+1-406-3880480

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio-0.308201732042792
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPS($19.63)
Net IncomeN/A
Net Margins-43.03%
Return on EquityN/A
Return on Assets-25.99%

Miscellaneous

EmployeesN/A
Outstanding Shares1,700,000

Xtant Medical (NYSEAMERICAN:XTNT) Frequently Asked Questions

What is Xtant Medical's stock symbol?

Xtant Medical trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "XTNT."

When did Xtant Medical's stock split? How did Xtant Medical's stock split work?

Xtant Medical's stock reverse split on the morning of Wednesday, February 14th 2018. The 1-12 reverse split was announced on Tuesday, February 13th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 13th 2018. An investor that had 100 shares of Xtant Medical stock prior to the reverse split would have 8 shares after the split.

How were Xtant Medical's earnings last quarter?

Xtant Medical Holdings Inc (NYSEAMERICAN:XTNT) posted its quarterly earnings results on Tuesday, May, 9th. The medical device company reported ($3.46) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($3.54) by $0.08. The medical device company earned $22.08 million during the quarter. View Xtant Medical's Earnings History.

Where is Xtant Medical's stock going? Where will Xtant Medical's stock price be in 2018?

1 brokerages have issued 1-year target prices for Xtant Medical's shares. Their forecasts range from $10.00 to $10.00. On average, they anticipate Xtant Medical's stock price to reach $10.00 in the next year. View Analyst Ratings for Xtant Medical.

Are investors shorting Xtant Medical?

Xtant Medical saw a decrease in short interest in January. As of January 31st, there was short interest totalling 782,950 shares, a decrease of 9.6% from the January 12th total of 866,321 shares. Based on an average daily trading volume, of 193,317 shares, the days-to-cover ratio is presently 4.1 days. Approximately 5.9% of the shares of the stock are short sold.

Who are some of Xtant Medical's key competitors?

Who are Xtant Medical's key executives?

Xtant Medical's management team includes the folowing people:

  • Carl D. O'Connell, President, Chief Executive Officer (Age 53)
  • Darrel Lee Holmes, Chief Operating Officer (Age 62)
  • Gregory Juda Ph.D., Chief Scientific Officer (Age 39)
  • John K. Bakewell, Director (Age 55)
  • Michael Eggenberg, Director
  • Michael R. Mainelli Jr., Director (Age 55)
  • Robert E. McNamara, Director (Age 61)
  • Jeffrey J. Peters, Director

Who owns Xtant Medical stock?

Xtant Medical's stock is owned by many different of institutional and retail investors. Top institutional investors include Perkins Capital Management Inc. (1.86%) and Renaissance Technologies LLC (1.43%). View Institutional Ownership Trends for Xtant Medical.

Who sold Xtant Medical stock? Who is selling Xtant Medical stock?

Xtant Medical's stock was sold by a variety of institutional investors in the last quarter, including Perkins Capital Management Inc.. View Insider Buying and Selling for Xtant Medical.

Who bought Xtant Medical stock? Who is buying Xtant Medical stock?

Xtant Medical's stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC. View Insider Buying and Selling for Xtant Medical.

How do I buy Xtant Medical stock?

Shares of Xtant Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Xtant Medical's stock price today?

One share of Xtant Medical stock can currently be purchased for approximately $5.88.

How big of a company is Xtant Medical?

Xtant Medical has a market capitalization of $149.32 million.

How can I contact Xtant Medical?

Xtant Medical's mailing address is 664 Cruiser Ln, BELGRADE, MT 59714-9719, United States. The medical device company can be reached via phone at +1-406-3880480.


MarketBeat Community Rating for Xtant Medical (XTNT)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  54 (Vote Outperform)
Underperform Votes:  29 (Vote Underperform)
Total Votes:  83
MarketBeat's community ratings are surveys of what our community members think about Xtant Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Xtant Medical (NYSEAMERICAN:XTNT) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $10.00$18.00$30.00$30.00
Price Target Upside: 107.04% upside141.94% upside303.23% upside458.78% upside

Xtant Medical (NYSEAMERICAN:XTNT) Consensus Price Target History

Price Target History for Xtant Medical (NYSEAMERICAN:XTNT)

Xtant Medical (NYSEAMERICAN:XTNT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
2/14/2018Maxim GroupReiterated RatingBuy -> Buy$18.00 -> $10.00View Rating Details
11/30/2016AegisInitiated CoverageBuy$42.00View Rating Details
8/4/2016HC WainwrightReiterated RatingBuyView Rating Details
3/17/2016Brean CapitalReiterated RatingBuy$120.00View Rating Details
(Data available from 2/23/2016 forward)

Earnings

Xtant Medical (NYSEAMERICAN:XTNT) Earnings History and Estimates Chart

Earnings by Quarter for Xtant Medical (NYSEAMERICAN:XTNT)

Xtant Medical (NYSEAMERICAN XTNT) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/21/2017Q3 2017($5.64)$19.79 millionViewN/AView Earnings Details
8/9/2017Q2 2017($6.48)$21.41 millionViewN/AView Earnings Details
5/9/2017Q1 2017($3.54)($3.46)$22.08 millionViewListenView Earnings Details
3/9/2017Q4 2016($3.60)($3.68)$24.45 million$24.47 millionViewListenView Earnings Details
11/7/2016Q3 2016($3.84)($4.80)$22.80 million$23.09 millionViewN/AView Earnings Details
8/1/2016Q2 2016($4.80)($4.44)$22.25 million$21.46 millionViewN/AView Earnings Details
5/4/2016Q1($4.68)($5.28)$21.94 million$20.98 millionViewN/AView Earnings Details
3/15/2016Q415($2.64)$11.64$23.34 million$22.30 millionViewN/AView Earnings Details
11/11/2015Q3($1.80)($7.68)$19.64 million$17.69 millionViewListenView Earnings Details
8/12/2015($3.48)($4.92)$10.15 million$9.89 millionViewN/AView Earnings Details
5/5/2015Q1 2015($3.36)($6.60)$9.60 million$9.50 millionViewN/AView Earnings Details
3/17/2015Q414($4.20)($5.52)$8.90 million$9.10 millionViewN/AView Earnings Details
11/5/2014($2.76)($2.28)$8.45 millionViewN/AView Earnings Details
8/12/2014Q214($5.64)($4.20)$8.85 million$5.60 millionViewN/AView Earnings Details
5/6/2014Q114($0.48)($0.96)$9.73 million$8.90 millionViewN/AView Earnings Details
3/19/2014Q413($0.84)($0.96)$8.00 million$8.30 millionViewN/AView Earnings Details
11/7/2013Q3 2013($4.80)($9.60)$8.91 million$7.93 millionViewN/AView Earnings Details
8/6/2013Q2 2013($4.80)($7.20)$9.25 million$8.27 millionViewN/AView Earnings Details
5/9/2013Q1 2013($0.72)($0.48)$10.08 million$8.62 millionViewN/AView Earnings Details
3/26/2013Q4 2012($4.80)($13.20)ViewN/AView Earnings Details
11/7/2012Q312($0.48)($0.72)$9.29 million$8.90 millionViewN/AView Earnings Details
8/9/2012($0.60)$0.24ViewN/AView Earnings Details
5/3/2012($0.48)($0.36)ViewN/AView Earnings Details
3/22/2012Q4 2011($4.80)($9.96)ViewN/AView Earnings Details
11/10/2011Q3 2011($1.20)($5.64)ViewN/AView Earnings Details
8/11/2011Q2 2011($7.20)($1.20)ViewN/AView Earnings Details
5/12/2011Q1 2011($6.24)ViewN/AView Earnings Details
3/28/2011Q4 2010($10.32)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Xtant Medical (NYSEAMERICAN:XTNT) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Xtant Medical (NYSEAMERICAN:XTNT)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Xtant Medical (NYSEAMERICAN XTNT) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Xtant Medical (NYSEAMERICAN:XTNT)
Institutional Ownership by Quarter for Xtant Medical (NYSEAMERICAN:XTNT)

Xtant Medical (NYSEAMERICAN XTNT) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/9/2016Daniel S GoldbergerCEOBuy5,000$2.34$11,700.0015,510View SEC Filing  
12/3/2015Kent L. SwansonDirectorBuy3,300$2.83$9,339.0083,128View SEC Filing  
11/20/2015David Louis KirschmanEVPBuy2,000$2.99$5,980.001,701,063View SEC Filing  
11/20/2015Kent L. SwansonDirectorBuy5,000$3.00$15,000.0079,828View SEC Filing  
11/19/2015David Louis KirschmanEVPBuy2,000$2.90$5,800.001,699,063View SEC Filing  
11/16/2015Daniel S GoldbergerCEOBuy3,000$2.80$8,400.0015,510View SEC Filing  
9/4/2015Daniel S GoldbergerCEOBuy81,522$3.68$300,000.9612,510View SEC Filing  
9/4/2015Jon M WickwireDirectorBuy10,869$3.68$39,997.9231,247View SEC Filing  
5/22/2014Daniel S GoldbergerCEOBuy25,000$0.65$16,250.00View SEC Filing  
5/20/2014Gregory Alexander JudaInsiderBuy20,000$0.69$13,800.00View SEC Filing  
5/7/2014Guy S CookMajor ShareholderSell1,365,000$0.66$900,900.00View SEC Filing  
5/6/2014Guy S CookMajor ShareholderSell885,000$0.75$663,750.00View SEC Filing  
5/2/2014Guy S CookMajor ShareholderSell280,000$0.73$204,400.00View SEC Filing  
4/30/2014Guy S CookMajor ShareholderSell85,000$0.70$59,500.00View SEC Filing  
4/25/2014Guy S CookMajor ShareholderSell100,000$0.70$70,000.00View SEC Filing  
4/24/2014Guy S CookMajor ShareholderSell390,000$0.70$273,000.00View SEC Filing  
4/22/2014Guy S CookMajor ShareholderSell410,000$0.71$291,100.00View SEC Filing  
4/17/2014Guy S CookMajor ShareholderSell75,000$0.70$52,500.00View SEC Filing  
4/9/2014Guy S CookMajor ShareholderSell410,000$0.72$295,200.00View SEC Filing  
1/15/2014Guy S CookMajor ShareholderBuy160,000$0.64$102,400.00View SEC Filing  
1/7/2014Guy S CookMajor ShareholderSell273,300$0.53$144,849.00View SEC Filing  
12/26/2013Guy S CookMajor ShareholderSell64,380$0.53$34,121.40View SEC Filing  
12/24/2013Guy S CookMajor ShareholderSell300,000$0.44$132,000.00View SEC Filing  
12/11/2013Guy S CookMajor ShareholderSell160,000$0.42$67,200.00View SEC Filing  
11/19/2013Gregory Alexander JudaInsiderBuy20,000$0.45$9,000.00View SEC Filing  
11/12/2013Daniel S GoldbergerCEOBuy50,000$0.48$24,000.00View SEC Filing  
9/20/2013Guy S CookMajor ShareholderSell30,000$0.60$18,000.00View SEC Filing  
9/13/2013Darrel Lee HolmesCOOSell30,000$0.57$17,100.00View SEC Filing  
8/28/2013Guy S CookMajor ShareholderSell400,000$0.56$224,000.00View SEC Filing  
8/26/2013Daniel S GoldbergerCEOBuy20,000$0.60$12,000.00View SEC Filing  
8/19/2013Daniel S GoldbergerCEOBuy16,194$0.59$9,554.46View SEC Filing  
8/16/2013Daniel S GoldbergerCEOBuy13,806$0.58$8,007.48View SEC Filing  
6/18/2013Guy S CookMajor ShareholderSell372,859$0.52$193,886.68View SEC Filing  
6/13/2013Guy S CookMajor ShareholderSell175,000$0.55$96,250.00View SEC Filing  
6/13/2013Kent L SwansonDirectorBuy100,000$0.55$55,000.00View SEC Filing  
6/12/2013Guy S CookMajor ShareholderSell2,600$0.55$1,430.00View SEC Filing  
6/11/2013Guy S CookMajor ShareholderSell21,000$0.56$11,760.00View SEC Filing  
6/10/2013Guy S CookMajor ShareholderSell13,400$0.56$7,504.00View SEC Filing  
6/7/2013Guy S CookMajor ShareholderSell88,000$0.56$49,280.00View SEC Filing  
9/11/2012Guy S CookCEOBuy5,000$1.71$8,550.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Xtant Medical (NYSEAMERICAN XTNT) News Headlines

Source:
DateHeadline
BRIEF-Xtant Medical Entered Twenty-Third Amendment To Amended Credit AgreementBRIEF-Xtant Medical Entered Twenty-Third Amendment To Amended Credit Agreement
www.reuters.com - February 17 at 9:10 AM
Xtant Medical regains compliance with NYSE American after converting debtXtant Medical regains compliance with NYSE American after converting debt
seekingalpha.com - February 17 at 9:10 AM
Why Did Xtant Medical Holdings Inc (XTNT) Shares Shoot the Lights Out Today?Why Did Xtant Medical Holdings Inc (XTNT) Shares Shoot the Lights Out Today?
finance.yahoo.com - February 16 at 4:25 PM
Xtant Medical Holdings (XTNT) Reports Compliance with NYSE AmericanXtant Medical Holdings (XTNT) Reports Compliance with NYSE American
www.streetinsider.com - February 16 at 9:19 AM
Xtant Medical issues 10.4M shares of stock in convertible debt exchangeXtant Medical issues 10.4M shares of stock in convertible debt exchange
seekingalpha.com - February 15 at 4:24 PM
Maxim Group Reiterates Buy Rating for Xtant Medical (XTNT)Maxim Group Reiterates Buy Rating for Xtant Medical (XTNT)
www.americanbankingnews.com - February 14 at 6:00 PM
Xtant Medical Announces Exchange of Outstanding Convertible Notes and Closing of Private PlacementXtant Medical Announces Exchange of Outstanding Convertible Notes and Closing of Private Placement
finance.yahoo.com - February 14 at 4:38 PM
Xtant Medical Holdings Inc (XTNT) Short Interest UpdateXtant Medical Holdings Inc (XTNT) Short Interest Update
www.americanbankingnews.com - February 9 at 6:36 PM
Xtant Medical Holdings Inc (XTNT) Short Interest Down 5.1% in JanuaryXtant Medical Holdings Inc (XTNT) Short Interest Down 5.1% in January
www.americanbankingnews.com - January 25 at 1:32 AM
Who Really Owns Xtant Medical Holdings Inc (NYSEMKT:XTNT)?Who Really Owns Xtant Medical Holdings Inc (NYSEMKT:XTNT)?
finance.yahoo.com - January 22 at 5:39 PM
Xtant Medical Enters into Restructuring and Exchange Agreement with All Holders of Outstanding Convertible NotesXtant Medical Enters into Restructuring and Exchange Agreement with All Holders of Outstanding Convertible Notes
finance.yahoo.com - January 18 at 11:02 AM
Before You Buy Xtant Medical Holdings Inc’s (NYSEMKT:XTNT), You Should Consider ThisBefore You Buy Xtant Medical Holdings Inc’s (NYSEMKT:XTNT), You Should Consider This
finance.yahoo.com - January 15 at 4:27 PM
Xtant Medical Holdings Inc (XTNT) Short Interest Down 6.3% in DecemberXtant Medical Holdings Inc (XTNT) Short Interest Down 6.3% in December
www.americanbankingnews.com - January 11 at 1:22 AM
What’s Ahead For Xtant Medical Holdings Inc (NYSEMKT:XTNT)?What’s Ahead For Xtant Medical Holdings Inc (NYSEMKT:XTNT)?
finance.yahoo.com - January 6 at 4:24 PM
Is Xtant Medical Holdings Inc’s (NYSEMKT:XTNT) CEO Pay Fair?Is Xtant Medical Holdings Inc’s (NYSEMKT:XTNT) CEO Pay Fair?
finance.yahoo.com - December 29 at 4:23 PM
Xtant Medical Holdings, Inc. :XTNT-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017Xtant Medical Holdings, Inc. :XTNT-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017
finance.yahoo.com - December 27 at 1:05 PM
At $0.5795, Is It Time To Buy Xtant Medical Holdings Inc (NYSEMKT:XTNT)?At $0.5795, Is It Time To Buy Xtant Medical Holdings Inc (NYSEMKT:XTNT)?
finance.yahoo.com - December 14 at 4:57 PM
Short Interest in Xtant Medical Holdings Inc (XTNT) Declines By 1.0%Short Interest in Xtant Medical Holdings Inc (XTNT) Declines By 1.0%
www.americanbankingnews.com - November 28 at 1:04 AM
Maxim Group Reaffirms "Buy" Rating for Xtant Medical Holdings Inc (XTNT)Maxim Group Reaffirms "Buy" Rating for Xtant Medical Holdings Inc (XTNT)
www.americanbankingnews.com - November 23 at 3:18 PM
Xtant Medical Holdings Inc (XTNT) Sees Significant Drop in Short InterestXtant Medical Holdings Inc (XTNT) Sees Significant Drop in Short Interest
www.americanbankingnews.com - November 14 at 6:02 PM

SEC Filings

Xtant Medical (NYSEAMERICAN:XTNT) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Xtant Medical (NYSEAMERICAN:XTNT) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Xtant Medical (NYSEAMERICAN XTNT) Stock Chart for Friday, February, 23, 2018

Loading chart…

This page was last updated on 2/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.